HLN - Haleon plc
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements.
As of Oct 13, 2026: spot at $9.43, ATM IV 50.0%, max pain $10.00, net GEX $194.7K.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Market Cap
- $41.57B
- P/E Ratio
- 19.62
- Beta
- 0.24
- 52-Week Range
- 8.65-11.28
- Dividend Yield
- $0.12
- CEO
- Brian James McNamara
- Employees
- 24,535
- IPO Date
- Jul 25, 2022
- Exchange
- NYSE
What HLN Looks Like to Options Traders Today
IV rank of 9.6% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); positive net gamma exposure ($194.7K) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (0.002) is roughly flat across the wings.
What This Page Covers
The HLN overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked HLN overview questions
- What is HLN?
- HLN is the ticker symbol for Haleon plc, a listed security. Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Listed on NYSE. HLN is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the HLN options snapshot look like today?
- As of Oct 13, 2026, the HLN options snapshot shows spot at $9.43, ATM IV 50.0%, IV rank 9.6%, max pain $10.00, net GEX $194.7K, expected move 14.33%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are HLN's key statistics?
- Haleon plc (HLN) carries a market capitalization of $41.57B, trailing P/E ratio of 19.62, beta of 0.24 relative to the broader market, 52-week range of 8.65-11.28. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does HLN belong to?
- Haleon plc operates in the Healthcare sector, in the Drug Manufacturers - Specialty & Generic industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare HLN's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the HLN data on this page?
- The options snapshot above is dated Oct 13, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, twice-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).